A randomized control trial of elective induction at 40 weeks and 41 weeks to prevent prolonged pregnancy.
- Disease/Condition
- Obstetrics and Gynecology
- Primary sponsor
- IPINNIMO OLUWADARE MARTINS
- Funder
- MYSELF
- Location
- Nigeria
- Phase
- Not Applicable
- Start date
- Jan 01, 1900
- End date
- Jan 01, 1900
BACKGROUND: Prolonged pregnancy is a major cause of perinatal and maternal morbidity and mortality and also a source of significant anxiety to the pregnant woman and family. Data has shown that the lowest incidence of perinatal morbidity and mortality is between 39 and 40 weeks gestation. A policy of routine induction of labour at 40 weeks could further reduce perinatal mortality and morbidity without increasing maternal anxiety and cesarean section rate . OBJECTIVES: The overall objective of the study is to compare obstetrics and perinatal outcomes of induction of labour at 40 weeks versus 41 weeks in healthy woman with low risk singleton pregnancy.
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR202306581858623
- Type
- Non-Device Trial
Access comprehensive clinical trial information for PACTR202306581858623 through Pure Global AI's free database. This Not Applicable trial is sponsored by IPINNIMO OLUWADARE MARTINS and is currently Recruiting. The study focuses on Obstetrics and Gynecology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.